Integration analysis identifies MYBL1 as a novel immunotherapy biomarker affecting the immune microenvironment in clear cell renal cell carcinoma: Evidence based on machine learning and experiments

BACKGROUND: Previous studies have identified MYBL1 as a cancer-promoting molecule in numerous types of cancer. Nevertheless, the role of MYBL in renal cancer remains unclear. METHODS: Genomic and clinical data of clear cell renal cell carcinoma (ccRCC) was get from the Cancer Genome Atlas (TCGA) dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tengda, Jian, Wengang, Xue, Wei, Meng, Yuyang, Xia, Zhinan, Li, Qinchen, Xu, Shenhao, Dong, Yu, Mao, Anli, Zhang, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794576/
https://www.ncbi.nlm.nih.gov/pubmed/36591240
http://dx.doi.org/10.3389/fimmu.2022.1080403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794576/
https://www.ncbi.nlm.nih.gov/pubmed/36591240
http://dx.doi.org/10.3389/fimmu.2022.1080403

Ejemplares similares